Jitendra Wadhane - Mar 26, 2024 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
SVP, Chief Accounting Officer
Signature
/s/ Jitendra Wadhane
Stock symbol
PYXS
Transactions as of
Mar 26, 2024
Transactions value $
$0
Form type
4
Date filed
3/28/2024, 04:31 PM
Previous filing
Nov 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +131K +49.26% $0.00 398K Mar 26, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.